| P2093 | author name string | Leaf HL | |
| | Jacobs AV | |
| P2860 | cites work | Blastomycosis as an etiology of acute lung injury | Q77318317 |
| | Coccidioidomycosis: an update | Q77339383 |
| | Acute respiratory failure associated with cryptococcosis in patients with AIDS: analysis of predictive factors | Q77595479 |
| | Echinocandins and pneumocandins--a new antifungal class with a novel mode of action | Q28258298 |
| | Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts | Q28368930 |
| | Stereoselective interaction of the azole antifungal agent SCH39304 with the cytochrome P-450 monooxygenase system isolated from Cryptococcus neoformans | Q28379017 |
| | Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation | Q28379104 |
| | In vitro comparative efficacy of voriconazole and itraconazole against fluconazole-susceptible and -resistant Cryptococcus neoformans isolates | Q28379437 |
| | Efficacy of LY303366 against amphotericin B-susceptible and -resistant Aspergillus fumigatus in a murine model of invasive aspergillosis | Q28379470 |
| | Isolation of specific DNA probes for detection of Cryptococcus neoformans | Q32117783 |
| | Treatment of histoplasmosis with MK-991 (L-743,872) | Q33690643 |
| | Susceptibilities of clinical and laboratory isolates of Blastomyces dermatitidis to ketoconazole, itraconazole, and fluconazole | Q33693076 |
| | Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. | Q33693515 |
| | Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in mice | Q33757174 |
| | Importance of interleukin-10 in genetic susceptibility of mice to Coccidioides immitis | Q33762670 |
| | Immunogenicity and protective efficacy of the WI-1 adhesin of Blastomyces dermatitidis | Q33767890 |
| | Endemic mycosis complicating human immunodeficiency virus infection | Q34183291 |
| | Blastomycosis--Wisconsin, 1986-1995. | Q34386443 |
| | A coccidioidomycosis outbreak following the Northridge, Calif, earthquake | Q34419065 |
| | Epidemiology of human blastomycosis in Vilas County, Wisconsin. II: 1991-1996. | Q34470805 |
| | Histoplasmosis and blastomycosis | Q34734019 |
| | Efficacies of two novel azole derivatives each containing a morpholine ring, UR-9746 and UR-9751, against systemic murine coccidioidomycosis | Q35131752 |
| | Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis | Q35137242 |
| | Vaccination with recombinant heat shock protein 60 from Histoplasma capsulatum protects mice against pulmonary histoplasmosis | Q35422849 |
| | Coccidioidomycosis: a reemerging infectious disease | Q37062231 |
| | Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils | Q37384429 |
| | The laboratory evaluation of opportunistic pulmonary infections | Q37885308 |
| | Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules. | Q39571294 |
| | Efficacy of nikkomycin Z against experimental pulmonary blastomycosis | Q39784951 |
| | Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components. | Q39830210 |
| | Pulmonary invasive aspergillosis in patients infected with the human immunodeficiency virus: report of two cases | Q40641413 |
| | Epidemiological and clinical features of pulmonary blastomycosis. | Q40646193 |
| | Asymptomatic solitary pulmonary nodules due to Cryptococcus neoformans in patients infected with human immunodeficiency virus | Q40663084 |
| | Coccidioidomycosis in patients infected with human immunodeficiency virus: review of 91 cases at a single institution | Q40664606 |
| | Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group. | Q40686828 |
| | Role of azoles in antifungal therapy | Q41045041 |
| | Induction of human immunodeficiency virus type 1 expression in monocytic cells by Cryptococcus neoformans and Candida albicans | Q41098013 |
| | Pulmonary aspergillosis: a spectrum of disease. | Q41309307 |
| | Pulmonary aspergilloma and AIDS. A comparison of HIV-infected and HIV-negative individuals | Q41445307 |
| | Blastomycosis in the immunocompromised patient. | Q41602711 |
| | Update and review of blastomycosis | Q41602731 |
| | Histoplasmosis. Experience during outbreaks in Indianapolis and review of the literature | Q41628684 |
| | Pulmonary coccidioidomycosis in Japan: case report and review | Q41663912 |
| | What makes Cryptococcus neoformans a pathogen? | Q41695186 |
| | Comparative study of antifungal activity of sertaconazole, terbinafine, and bifonazole against clinical isolates of Candida spp., Cryptococcus neoformans and dermatophytes | Q42546148 |
| | Treatment of blastomycosis with higher doses of fluconazole. The National Institute of Allergy and Infectious Diseases Mycoses Study Group | Q42665247 |
| | Atypical cytomorphologic appearance of Cryptococcus neoformans: a report of five cases | Q43440144 |
| | Blastomycosis in northeast Tennessee | Q43527939 |
| | Coccidioidomycosis--Arizona, 1990-1995. | Q44131000 |
| | Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group | Q44474075 |
| | Septic shock in coccidioidomycosis | Q44563529 |
| | Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis. | Q44952024 |
| | Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area | Q45780021 |
| | Molecular markers reveal differentiation among isolates of Coccidioides immitis from California, Arizona and Texas | Q46210980 |
| | Is it ever safe to stop azole therapy for Coccidioides immitis meningitis? | Q46734347 |
| | Immunologic, genetic and social human risk factors associated to histoplasmosis: studies in the State of Guerrero, Mexico | Q47333606 |
| | Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group. | Q47779353 |
| | Effect of antibody to capsular polysaccharide on eosinophilic pneumonia in murine infection with Cryptococcus neoformans | Q48023943 |
| | Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses administered over a relatively short period | Q49295342 |
| | Risk factors and outcomes associated with identification of Aspergillus in respiratory specimens from persons with HIV disease. Pulmonary Complications of HIV Infection Study Group. | Q50874925 |
| | Prevalence of serotype D in Cryptococcus neoformans isolates from HIV positive and HIV negative patients in Italy. | Q50906504 |
| | Analysis of compassionate use itraconazole therapy for invasive aspergillosis by the NIAID Mycoses Study Group criteria. | Q51193756 |
| | An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis. | Q53349495 |
| | Successful treatment of disseminated coccidioidomycosis with amphotericin B lipid complex. | Q53755540 |
| | Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. | Q53950594 |
| | Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trial. | Q53963189 |
| | Cryptococcus neoformans differently regulates B7-1 (CD80) and B7-2 (CD86) expression on human monocytes | Q56907964 |
| | Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery | Q57220656 |
| | Invasive Pulmonary Aspergillosis in Patients with Chronic Obstructive Pulmonary Disease: Report of Eight Cases and Review | Q57238104 |
| | Regulatory role of exogenous IL-10 in the development of immune response versus Cryptococcus neoformans | Q63247606 |
| | Serum cryptococcal antigen in patients with AIDS | Q71762032 |
| | Fluconazole therapy for histoplasmosis. The National Institute of Allergy and Infectious Diseases Mycoses Study Group | Q71786842 |
| | High-resolution computed tomography and pathologic findings in pulmonary aspergillosis: a pictorial essay | Q71834918 |
| | Histoplasmosis: recognition and treatment | Q72775364 |
| | Evaluation of cultures of percutaneous core needle biopsy specimens in the diagnosis of pulmonary nodules | Q73047374 |
| | Mannoproteins of Cryptococcus neoformans induce proliferative response in human peripheral blood mononuclear cells (PBMC) and enhance HIV-1 replication | Q73068254 |
| | Cavitary cryptococcoma of the lungs and meningitis by Cryptococcus neoformans in a patient with AIDS | Q73247958 |
| | Coccidioidomycosis in liver transplant patients | Q73255307 |
| | Fungal pneumonias | Q73438866 |
| | Synchronous pulmonary cryptococcosis and histoplasmosis | Q73515943 |
| | Pulmonary blastomycosis with acute respiratory failure as predominant clinical feature | Q73589749 |
| | Combination therapy with fluconazole and flucytosine for pulmonary cryptococcosis | Q73935634 |
| | A case of allergic bronchopulmonary aspergillosis successfully treated with itraconazole | Q74369780 |
| | Invasive aspergillosis | Q74492548 |
| | Surgical therapy for pulmonary aspergillosis in immunocompromised patients | Q74570514 |
| | Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease | Q74593278 |
| | Invasive aspergillosis. Clinical features of 35 proven cases at a single institution | Q74754465 |
| | Coccidioidomycosis in Hungary. The first import case | Q74757922 |
| | Pulmonary aspergillosis and invasive disease in AIDS: review of 342 cases | Q74800410 |
| | Acute pulmonary histoplasmosis: progressive pneumonia resulting from high inoculum exposure | Q74803729 |
| | [Aspergillus antigen detection: comparison of a new sandwich ELISA with the latex agglutination test in patients with histologically proven invasive aspergillosis] | Q77148926 |
| P433 | issue | 1 | |
| P304 | page(s) | 89-98 | |
| P577 | publication date | 1999-04-01 | |
| P1433 | published in | Current infectious disease reports | Q26842136 |
| P1476 | title | Fungal Infections of the Lung | |
| P478 | volume | 1 | |